XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Paid-in Capital
Retained Earnings (Accumulated Deficit)
Beginning balance (in shares) at Sep. 30, 2021   31,294    
Beginning balance at Sep. 30, 2021 $ 724,884 $ 31 $ 866,158 $ (141,305)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 79,557     79,557
Net comprehensive income 79,557     79,557
Stock-based compensation expense 4,532   4,532  
Stock option exercises (in shares)   1    
Stock option exercises 4   4  
Shares issued under employee stock plans, net (in shares)   517    
Forfeiture and other settlements of restricted stock (in shares)   (47)    
Common stock redeemed for tax liability (in shares)   (307)    
Common stock redeemed for tax liability (6,620)   (6,620)  
Ending balance (in shares) at Mar. 31, 2022   31,458    
Ending balance at Mar. 31, 2022 802,357 $ 31 864,074 (61,748)
Beginning balance (in shares) at Dec. 31, 2021   31,460    
Beginning balance at Dec. 31, 2021 755,259 $ 31 861,648 (106,420)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 44,672     44,672
Net comprehensive income 44,672     44,672
Stock-based compensation expense 2,424   2,424  
Stock option exercises $ 4   4  
Shares issued under employee stock plans, net (in shares) 1      
Forfeiture and other settlements of restricted stock (in shares)   (3)    
Common stock redeemed for tax liability $ (2)   (2)  
Ending balance (in shares) at Mar. 31, 2022   31,458    
Ending balance at Mar. 31, 2022 802,357 $ 31 864,074 (61,748)
Beginning balance (in shares) at Sep. 30, 2022   30,880    
Beginning balance at Sep. 30, 2022 939,286 $ 31 859,856 79,399
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 59,038     59,038
Net comprehensive income 59,038     59,038
Stock-based compensation expense 3,258   3,258  
Shares issued under employee stock plans, net (in shares)   675    
Forfeiture and other settlements of restricted stock (in shares)   (3)    
Common stock redeemed for tax liability (in shares)   (205)    
Common stock redeemed for tax liability (2,597)   (2,597)  
Ending balance (in shares) at Mar. 31, 2023   31,347    
Ending balance at Mar. 31, 2023 998,985 $ 31 860,517 138,437
Beginning balance (in shares) at Dec. 31, 2022   31,347    
Beginning balance at Dec. 31, 2022 962,600 $ 31 858,839 103,730
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 34,707     34,707
Net comprehensive income 34,707     34,707
Stock-based compensation expense 1,678   1,678  
Shares issued under employee stock plans, net (in shares)   3    
Forfeiture and other settlements of restricted stock (in shares)   (3)    
Ending balance (in shares) at Mar. 31, 2023   31,347    
Ending balance at Mar. 31, 2023 $ 998,985 $ 31 $ 860,517 $ 138,437